| 7TM receptors | seven transmembrane domain receptors, also known as G protein-coupled receptors (GPCRs) |
| 9-PAHSA | palmitic-acid-9-hydroxy-stearic-acid |
| Ω-3 FAs | omega-3-fatty acids |
| AD | Alzheimer’s disease |
| ALA | alpha-linolenic acid |
| ANGPTL2 | angiopoietin-like 2 protein |
| APCs | antigen-presenting cells |
| ARRβ2 | beta-arrestin 2 |
| AT | adipose tissue |
| ATP | adenosine triphosphate |
| BAT | brown adipose tissue |
| BMI | body mass index |
| cAMP | cyclic adenosine 3,5-monophosphate |
| CCK | cholecystokinin |
| CICR | calcium-induced calcium release |
| CNS | central nervous system |
| cpdA | compound A |
| CRF2 | corticotropin-releasing factor type-2 |
| CRF2R | corticotropin-releasing factor type-2 receptor |
| CTL | cytotoxic T lymphocyte |
| DAG | diacyl glycerol |
| DHA | docosahexaenoic acid |
| DIO | diet-induced obesity |
| DPP-IV | dipeptidyl peptidase-IV |
| EC50 | half maximal effective concentration |
| ECL1–ECL3 | three extracellular loops (from 1 to 3) forming the GPCR |
| eNAMPT | extracellular nicotinamide phosphoribosyl transferase |
| EPA | eicosapentaenoic acid |
| ERK1/2 | extracellular regulated protein kinases 1/2 |
| ERKs | extracellular signal-regulated kinases |
| FDA | U.S. Food and Drug Administration |
| FFAR1 | free fatty acid receptor 1, also known as GPR40 |
| FFAR4 | free fatty acid receptor 4, also known as GPR120 |
| FFAs | free fatty acids |
| FGF-21 | fibroblast growth factor-21 |
| GDP | guanosine diphosphate |
| GEF | guanine nucleotide exchange factor |
| GHIH | growth hormone-inhibiting hormone, also known as somatotropin release inhibiting factor (SRIF) |
| GIP | gastric inhibitory polypeptide, also known as glucose-dependent insulinotropic polypeptide |
| GLP-1 | glucagon-like peptide-1 |
| GLUT4 | glucose transporter type 4 |
| GPCRs | G protein-coupled receptors, also known as seven transmembrane domain (7TM) receptors |
| GPR40 | G protein-coupled receptor 40, also known as FFAR1 |
| GPR120 | G protein-coupled receptor 120, also known as FFAR4 |
| GPR120L | a long form of GPR120, |
| GPR120S | a short form of GPR120 |
| GRAFS | acronym defining classification of GPCRs that stands for glutamate, rhodopsin, adhesion, Frizzled/Taste2, and Secretin |
| GSIS | glucose-stimulated insulin secretion |
| GSSS | glucose-stimulated somatostatin secretion |
| GTP | guanosine triphosphate |
| HbA1c | hemoglobin A1C |
| HDL | high-density lipoprotein |
| HEC | human embryonic kidney |
| HFD | high-fat diet |
| HIF-1 | hypoxia-induced factor 1 |
| ICL1–ICL3 | three intracellular loops (from 1 to 3) forming the GPCR |
| IFN-γ | interferon gamma |
| IKKβ | nuclear factor kappa-B kinase |
| IL1R | interleukin 1 receptor |
| IL-1RA | interleukin 1 receptor antagonist |
| ILs | interleukins, including IL-1β, IL-6, IL-8), |
| iNAMPT | intracellular nicotinamide phosphoribosyl transferase |
| INSR | insulin receptor |
| IP3 | inositol 1,4,5-trisphosphate |
| IR | insulin resistance |
| IRSs | insulin receptor substrates |
| IVGTT | intravenous glucose tolerance test |
| JNK | c-Jun N-terminal kinase |
| KATP | ATP-sensitive potassium channels |
| LA | linolenic acid |
| LCFAs | long-chain fatty acids |
| LPS | lipopolysaccharide |
| MAP3K7 | TGF-β activated kinase 1 |
| M1, M2 macrophages | classically activated and alternatively activated macrophages, respectively |
| MARTs | mono ADP-ribosyl transferases |
| MCFAs | medium-chain fatty acids |
| MCP-1 | monocyte chemoattractant protein-1, also known as CCL2 |
| MMPs | matrix metalloproteinases |
| MiMP | mitochondrial membrane potential |
| NAc | nucleus accumben |
| N.A.D. | denotes no data or ambiguous data |
| NAFLD | nonalcoholic fatty liver disease |
| NAMPT | nicotinamide phosphoribosyl transferase |
| NCG | N-Carbamoyl-Beta-D-Glucopyranosylamine |
| NEMO | nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB) essential modulator |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 inflammasome | nucleotide-binding oligomerization domain (NOD), leucine-rich repeat (LRR)-containing protein (NLR) family member 3 inflammasome |
| PARPs | poly ADP-ribose polymerases |
| PC1/3 | proprotein convertase 1/3 |
| PDX1 | pancreatic duodenal homeobox-1 |
| pERK1/2 | phosphorylated extracellular regulated protein kinases 1/2 |
| PI3K | phosphoinositide 3-kinase |
| PIP2 | phosphatidylinositol 4,5-bisphosphate |
| PKC | protein kinase C |
| PLC-β | phospholipase C-beta |
| PPARγ | peroxisome proliferator-activated receptor gamma |
| PUFAs | polyunsaturated fatty acids |
| RAW 264.7 | monocyte/macrophage-like cell line |
| ROS | reactive oxygen species |
| RXRα | retinoid X receptor alpha |
| SAAs | sulfur amino acids |
| S1P | sphingosine-1-phosphate |
| S1P1 | sphingosine-1-phosphate receptor-1 |
| SCFAs | short-chain fatty acids |
| SNP | single-nucleotide polymorphism |
| SPM | specialized pro-resolving mediator |
| SRIF | somatotropin release inhibiting factor, also known as growth hormone-inhibiting hormone (GHIH) |
| STC-1 | secretin tumor cell line 1 |
| S-V cells | stromal–vascular cells |
| T2D | type 2 diabetes mellitus |
| TAB1 | TAK1 binding protein 1 |
| TAK1 | TGFβ-activated kinase 1 |
| TGFβ | transforming growth factor-beta |
| Th1, Th2, Th17 | types of lymphocyte subpopulations |
| TLR4 | Toll-like receptor 4 |
| TM1–TM7 | seven transmembrane heptahelical structures (from 1 to 7) forming GPCR |
| TNFR | tumor necrosis factor receptor |
| UCN3 | urocortin 3 |
| UCP1 | uncoupling protein 1 |
| VEGF | vascular endothelial growth factor |
| WAT | white adipose tissue |
| ZDF | Zucker Diabetic Fatty (rats) |